The Residual Risk Reduction Initiative

Your login
Your password
Confirm your password
Your email
I agree to receive the R3i newsletter
Yes No

Prof. Rody Sy

University of Philippines,
Manila, Philippines


Current position

	Professor, Section of Cardiology, Department of Medicine, UP College of Medicine, Manilla, Philippines Head, Cardiovascular Institute, Cardinal Santos Medical Center, San Juan, Philippines

Past position

1995 - 1998	Medical Director, Cardinal Santos Medical Center, San Juan, Philippines
1994 - 1999	Chief, Section of Cardiology, Department of Medicine, UP-PGH
1999 - 2000	Chairman, Specialty Board of Cardiology (Adult), Philippine College of Cardiology

Scientific training

1974	Doctor of Medicine, University of the Philippines
1974 - 1975	General Internship, UP-PGH Medical Center
1976 - 1979	Residency in Internal Medicine, UP-PGH Medical Center
1979 - 1982	Fellowship in Cardiology, Georgetown University Hospital, Washington, DC, USA
1983	Fellow and Diplomate, Philippine College of Physicians
1983	Fellow and Diplomate, Philippine College of Cardiology
1993	Fellow, American College of Cardiology

Professional Associations

2002 - 2006	President, Asian Pacific Society of Atherosclerosis and Vascular Diseases
1995 - 2002	President, Philippine Lipid Society
1991 - 1992	President, Philippine Heart Association
1993 - 2007	Trustee, Philippine Society of Hypertension

Awards

1996	Distinguished Fellow Award, Philippine College of Physicians
1998	Distinguished Service Award, Philippine Heart Association
1999	Distinguished Teacher Award, Philippine Heart Association
1999	Awardee, Most Distinguished Research in Cardiology, Philippine Heart Association,

Publications (selection)
Sy RG, Punzalan FER for the PACER 2 Study Group. A multicenter, open label, 8 week study evaluating the efficacy and safety of once daily Atorvastatin in patients with hyperlipidemia. Phil J Int Med 2000; 38: 273-278. Wu CC, Sy RG, Tanphaichitr V, Tan ATT, Suyono S, Lee YT. Comparing the efficacy and safety of Atorvastatin and Simvastatin in Asians with elevated low density lipoprotein cholesterol – A multinational multicenter double blind study. J Formos Med Assoc 2002; 101: 478-487. Sy RG, Dans AL, Punzalan FER, Amarillo ML, Velandria F for the FNRI-HDL Study Group. The prevalence of dyslipidemia, diabetes, hypertension, stroke and angina pectoris in the Philippines. Phil J Int Med 2003; 41: 1-6. Litonjua A, Sy RG, Abarquez R, Lim-Abrahan MA, Asis L, Babilonia N, Bautista JA, Crisostomo M, Dizon E, Go RT, Mirasol R, Paz-Pacheco E, Palafox P, Pastores E, Quimpo J, Raboca J, Reyes E, Sapang BD, Sison MO, Sy RA, Uy Z, Villadolid M, Chua P, Aragon J for Philippine XENLO Study Group. Lipid lowering effect of Orlistat beyond weight reduction in overweight / obese Filipino patients: An RCT study. Phil J Int Med 2004; 42(6): 297-305. Punzalan FER, Sy RG, Ty-Willing T. Prevalence of metabolic syndrome among adult Filipinos. International Congress Series 1262(2004): 442-445. Punzalan FER, Sy RG, Santos RS, Cutiongco EM, Gosiengfiao S, Fadriguilan E, George P. Low Density Lipoprotein- Receptor (LDL-R) gene mutation among Filipinos with Familial Hypercholesterolemia. J Atheroscl Thromb 2005;12: 276-283. Sy RG, Cutiongco EM, Punzalan FER, Santos RS, Geronimo FRB, Tangco RV. Human Cholesteryl ester transfer protein (Taq1B) polymorphism among Filipinos with cardiovascular risk factors. J Atheroscl Thromb 2007; 14(3). Sy RG, Encabo R, Soria ML, et al. Prevalence of metabolic syndrome in young Filipino college students 18-25 years old. (final drafting and for submission for publication soon)

Research

Research Interests	Metabolic Syndrome Familial Hypercholesterolemia Spearheaded the clinical arm in the 5th National Nutrition Survey 1998-99 with FNRI-DOST and DOH

Ongoing work	Philippine Cardiovascular Outcome Study (PhilCOS): An 8-year follow-up of the 1998 FNRI 5th NNS in the National Capital Region, Region 3 and Region 4. (Study will look at incidence of DM, prevalence of impaired fasting glucose, impaired glucose tolerance using standard oral glucose load. It will also look at predictability of Framingham CHD scoring system to Filipino subjects.) Factors affecting HDL-C levels among Filipinos. (To correlate all potential factors in the 2003 NNHeS survey affecting the low HDL-C level in the Philippines population.)